Coegin Pharma
4.36 SEK
+1.87 %
Less than 1K followers
COEGIN
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+1.87 %
-1.80 %
-12.45 %
-34.73 %
+27.49 %
+3.32 %
-62.25 %
-75.19 %
-86.29 %
Coegin Pharma is a Swedish biotechnology company in commercial phase, developing science-based innovations for hair and skin. The company's patented ingredient for hair growth is now available in products sold through selected partners. A peptide for natural skin pigmentation is also in development with a planned launch in the near future. Coegin Pharma is headquartered in Lund.
Read moreMarket cap
108.47M SEK
Turnover
15.57K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26/2
2026
Annual report '25
21/5
2026
Interim report Q1'26
21/5
2026
General meeting '26
All
Press releases
ShowingAll content types
Coegin Pharma appoints worldleading pigmentation and hair-biology expert Professor Desmond J. Tobin as Scientific Advisor
Coegin Pharma completes first delivery of Follicopeptide products to Hårklinikken
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools